Carcinoma of the paranasal sinuses results of a prospective pilot study
- 1 July 1985
Abstract
Sixty patients with paranasal sinus cancer were treated from Jan. 1976-July 1981 according to a standard protocol in which surgery is combined with a low dose of irradiation and a topically applied cytostatic drug. The local control rate was 65%. Mutilation was clearly reduced. The actuarial 2-yr and 5-yr survival rate was 76% and 65%, respectively. The actuarial 5-yr survival rate for squamous cell carcinoma and undifferentiated carcinoma of the maxillary sinus was 52%. For adenocarcinoma of the ethmoid sinus the actuarial 5-yr survival rate was 100%. The results of this prospective pilot study suggest that it may be possible to achieve better results with less aggressive treatment.This publication has 32 references indexed in Scilit:
- Malignant Tumours of the Nasal Cavity and Paranasal SinusesORL, 1983
- Reappraisal of trimodal combination therapy for maxillary sinus carcinomaCancer, 1982
- Maxillary sinus carcinomaThe Laryngoscope, 1981
- Radiotherapy and Head and Neck Cancer: Role of Lymphocyte Response and Clinical StageJAMA Otolaryngology–Head & Neck Surgery, 1980
- Carcinoma of the nasal cavity and paranasal sinuses: incidence and presentation of different histological typesClinical Otolaryngology, 1979
- Cellular immunity in patients with epidermoid cancer of the head and neckThe Laryngoscope, 1979
- Changing concepts of cancer surgery: Surgery as immunotherapyThe American Journal of Surgery, 1978
- Carcinoma of maxillary antrum: The role of pre‐operative irradiationThe Laryngoscope, 1974
- Combined Radiological and Surgical Therapy of Cancer of the EthmoidActa Oto-Laryngologica, 1974
- Cancer of the maxillary sinusThe Laryngoscope, 1971